Rantanen, JukkaRades, ThomasStrachan, Clare2023-12-132023-12-132023-11-30Rantanen, J, Rades, T & Strachan, C 2023, 'Solid-state analysis for pharmaceuticals : Pathways to feasible and meaningful analysis', Journal of Pharmaceutical and Biomedical Analysis, vol. 236, 115649. https://doi.org/10.1016/j.jpba.2023.115649ORCID: /0000-0003-3134-8918/work/177213049http://hdl.handle.net/10138/568408The solid state of matter is the preferred starting point for designing a pharmaceutical product. This is driven by both patient preferences and the relative ease of supplying a solid pharmaceutical product with desired quality and performance. Solid form diversity is increasingly prevalent as a crucial element in designing these products, which underpins the importance of solid-state analytical methods. This paper provides a critical analysis of challenges related to solid-state analytics, as well as considerations and suggestions for feasible and meaningful pharmaceutical analysis.7engcc_byinfo:eu-repo/semantics/openAccessAnalytical techniquesDosage formProcess analyticsProduct performanceSample preparationSolid-state propertiesPharmacyArticleopenAccesse63e5b11-e0df-4b3c-874b-aca971bf044c37657177001090713300001